Oncologists have crucial yet under-studied and often under-supported roles in promoting clinical trial referral and enrolment. Herein, we advocate for a systemic shift that acknowledges the operational barriers oncologists face and enhances structural support through streamlined workflows and behavioural science-informed strategies to facilitate their participation in clinical trial enrolment.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Unger, J. M. et al. National estimates of the participation of patients with cancer in clinical research studies based on Commission on Cancer accreditation data. J. Clin. Oncol. 42, 2139–2148 (2024).
Unger, J. M. et al. “When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J. Natl Cancer Inst. 113, 244–257 (2021).
Dolly, S. O. et al. A study of motivations and expectations of patients seen in phase 1 oncology clinics. Cancer 122, 3501–3508 (2016).
Durden, K. et al. Provider motivations and barriers to cancer clinical trial screening, referral, and operations: findings from a survey. Cancer. 130, 68–76 (2024).
Wong, A. R. et al. Barriers to participation in therapeutic clinical trials as perceived by community oncologists. JCO Oncol. Pract. 16, e849–858 (2020).
Michie, S., van Stralen, M. M. & West, R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement. Sci. 6, 42 (2011).
Waters M. AI meets informed consent: a new era for clinical trial communication. JNCI Cancer Spectr. 9, pkaf028 (2025).
Jin, Q. et al. Matching patients to clinical trials with large language models. Nat. Commun. 15, 9074 (2024).
Acknowledgements
The authors are exceptionally grateful for the pivotal contributions of T. Wang, Burnett School of Medicine at Texas Christian University, Fort Worth, TX, USA, whose keen insight, careful editorial revisions and crucial literature reviews were invaluable. We also owe a debt of gratitude to H. H. Moon, Kaiser Permanente Southern California, Riverside, CA, USA for her penetrating insights, thoughtful analysis and critical editorial improvements that substantially elevated this manuscript. Their expertise was indispensable to this project. The work of C.J. is supported by the Robert A. Winn Career Development Award and the ASCO Conquer Cancer Foundation Career Development Award.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Jiang, C., Nipp, R.D. & Zhang, T. Empowering oncologists: a practical approach to overcoming barriers to clinical trial enrolment. Nat Rev Clin Oncol 22, 541–542 (2025). https://doi.org/10.1038/s41571-025-01038-6
Published:
Issue date:
DOI: https://doi.org/10.1038/s41571-025-01038-6
